Insights into Immunocore Hldgs's Upcoming Earnings

Immunocore Hldgs (NASDAQ:IMCR) is preparing to release its quarterly earnings on Wednesday, 2026-02-25. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Immunocore Hldgs to report an earnings per share (EPS) of $-0.23.

Immunocore Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Overview of Past Earnings

Last quarter the company beat EPS by $0.26, which was followed by a 6.03% increase in the share price the next day.

Here's a look at Immunocore Hldgs's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.26	-0.21	-0.41	-0.24
EPS Actual	0.00	-0.20	0.10	-0.47
Price Change %	6.00	0.00	0.00	-4.00

Performance of Immunocore Hldgs Shares

Shares of Immunocore Hldgs were trading at $32.93 as of February 23. Over the last 52-week period, shares are up 8.25%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Immunocore Hldgs visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.